Diltiazem versus metoprolol for the management of atrial fibrillation: A systematic review and meta-analysis - 09/10/21
Doi : 10.1016/j.ajem.2021.06.053
S. Hammad Jafri, M.D., M.M.Sc a, e, ⁎ 
, Jing Xu, M.D., Ph.D., M.M.Sc a, b , Ibrahim Warsi, D.D.S, M.M.Sc a, c , Christian D. Cerecedo-Lopez, M.D., M.M.Sc a, d
, Jing Xu, M.D., Ph.D., M.M.Sc a, b , Ibrahim Warsi, D.D.S, M.M.Sc a, c , Christian D. Cerecedo-Lopez, M.D., M.M.Sc a, d a Master of Medical Sciences in Clinical Investigation Program, Harvard Medical School, Boston, MA, USA
b Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
c Department of Oral Medicine and Immunology, The Forsyth Institute, Harvard School of Dental Medicine, Boston, MA, USA
d Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
e Department of Medicine, Cardiology division, Providence VA Medical Center, Alpert Medical School, Brown University, Providence, RI, USA
⁎Corresponding author at: Cardiovascular Division, Department of Medicine Brown University, 830 Chalkstone Avenue, Providence, RI 02908, USA.Cardiovascular DivisionDepartment of Medicine Brown University830 Chalkstone AvenueProvidenceRI02908USA
Vol 48
P. 323-327 - octobre 2021 Retour au numéro
Article précédent
- Predictive value of cardiac markers in the prognosis of COVID-19 in children
- Ufuk Utku Güllü, ?ükrü Güngör, Sevcan ?pek, Sad?k Yurttutan, Cengiz Dilber
- Trauma outcomes for blunt and penetrating injuries by mode of transportation and day/night shift
- Mason Sutherland, Haley Ehrlich, Mark McKenney, Adel Elkbuli
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?